Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Oct 22 (Reuters) - Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after ...

The ECDC, the infectious diseases watchdog, has asked for scientists to join its new panel on RSV as Europe begins to vaccinate its most vulnerable adults.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

A healthcare worker places vials containing doses of the "Comirnaty" Pfizer BioNTech and Moderna vaccines against the coronavirus disease (COVID-19) on a table at a vaccination centre in Ronda, Spain ...